World Journal of Urology

, Volume 32, Issue 4, pp 1021–1025 | Cite as

Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation

  • Giovanni Palleschi
  • Antonio Luigi Pastore
  • Cristina Maggioni
  • Andrea Fuschi
  • Luca Pacini
  • Vincenzo Petrozza
  • Antonio Carbone
Original Article



Bladder dysfunction, secondary to diabetes, is mainly characterized by poor bladder emptying and overflow incontinence. However, there is evidence in literature that storage symptoms, as those suggestive for overactive bladder (OAB), may also affect people with diabetes. The aim of this study was to evaluate the prevalence of overactive bladder, the complaint of urinary urgency with/without urge incontinence, usually with frequency and nocturia, in people with diabetes compared to healthy subjects (control group).


Symptoms were assessed through the overactive bladder questionnaire (OAB-q), an investigative tool, specifically developed for OAB diagnosis.


OAB-q scores resulted higher in diabetic people than those of the control group. Age and disease duration resulted in measurements that showed a statistical correlation with the OAB-q scores.


OAB symptoms are more prevalent in diabetic people than in non-diabetic people. This prompts further research to determine whether the onset of OAB symptoms can be considered as an indicator of diabetic neuropathy.


Overactive bladder Diabetes mellitus Lower urinary tract symptoms Overactive bladder questionnaire 



Bladder outlet obstruction


Diabetes mellitus


Detrusor overactivity


Lower urinary tract symptoms


Mini-mental state examination


Overactive bladder


Overactive bladder questionnaire


Urinary tract infection


Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmstein U, Van Kerrebroek P, Victor A, Wein A (2003) The standardization of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61(1):37–49PubMedCrossRefGoogle Scholar
  2. 2.
    Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(1):S5–S20Google Scholar
  3. 3.
    Coyne K, Revicki D, Hunt T, Correy R, Stuart W, Bentkover J, Kurth H, Abrams P (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11(6):563–574PubMedCrossRefGoogle Scholar
  4. 4.
    Coyne KS, Tubaro A, Brubacker L, Bavendam T (2006) Development and validation of patient reported outcome measures for overactive bladder: a review of concepts. Urology 2006Google Scholar
  5. 5.
    Wiedemann A, Fugsen I (2010) The patient with diabetes in urologic practice: a special risk for lower urinary tract symptoms? Results of the Witten diabetes survey of 4071 type 2 diabetics. Urol A 49(2):238–244CrossRefGoogle Scholar
  6. 6.
    Pannek J (2010) Diagnosis and therapy of functional disorders of the bladder in persons with diabetes mellitus. What do we actually know? Urol A 49(3):381–386CrossRefGoogle Scholar
  7. 7.
    Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S (2009) Diabetic bladder dysfunction: current translational knowledge. J Urol 182(6 Suppl):S18–S26PubMedCrossRefGoogle Scholar
  8. 8.
    Lee WC, Wu HP, Tai TY, Yu HJ, Chiang PH (2009) Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes. J Urol 181(1):198–203PubMedCrossRefGoogle Scholar
  9. 9.
    Ding J, Qi L, Zu X, Shen P (2010) Urodynamic studies on benign prostatic hyperplasia combined with diabetes mellitus. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35(7):705–710PubMedGoogle Scholar
  10. 10.
    Ho CH, Tai HC, Yu HJ (2010) Urodynamic findings in female diabetic patients with and without overactive bladder symptoms. Neurourol Urodyn 29(3):424–427PubMedGoogle Scholar
  11. 11.
    Tong YC, Cheng JT (2007) Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats. J Urol 178(5):2203–2207PubMedCrossRefGoogle Scholar
  12. 12.
    Atalik KE, Okudan N, Gokbel H, Kalkan S, Cuce G (2010) Diabetes mellitus- and cooling-induced bladder contraction: an in vitro study. J Smooth Muscle Res 46(4):175–183PubMedCrossRefGoogle Scholar
  13. 13.
    Fayyad AM, Hill SR, Jones G (2009) Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int Urogynecol J 20:1339–1344CrossRefGoogle Scholar
  14. 14.
    Yamaguchi C, Sakakibara R, Uchiyama T, Yamamoto T, Ito T, Liu Z, Awa Y, Yamamoto K, Nomura F, Yamanishi T, Hattori T (2007) Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodyn 26(6):807–813PubMedCrossRefGoogle Scholar
  15. 15.
    Iacovelli E, Gilio F, Meco G, Fattapposta F, Vanacore N, Brusa L, Giacomelli E, Gabriele M, Rubino A, Locuratolo N, Iani C, Pichiorri F, Colosimo C, Carbone A, Palleschi G, Inghilleri M (2010) Bladder symptoms assessed with overactive bladder questionnaire in Parkinson’s disease. Mov Dis 25(9):1203–1209Google Scholar
  16. 16.
    Tubaro A (2004) Defining overactive bladder: epidemiology and burden of disease. Urology 64(6 Suppl 1):2–6PubMedCrossRefGoogle Scholar
  17. 17.
    Fayyad AM, Hill SR, Jones G (2010) Urine production and bladder diary measurements in women with type 2 diabetes mellitus and their relation to lower urinary tract symptoms and voiding dysfunction. Neurourol Urodyn 29(3):354–358PubMedGoogle Scholar
  18. 18.
    Lin TL, Chen GD, Chen YC, Huang CN, Ng SC (2012) Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes. Source Dep Living Sci Nat Open Univ Taiwan 51(3):381–386Google Scholar
  19. 19.
    Devore EE, Townsend MK, Resnick NM, Grodstein F (2012) The epidemiology of urinary incontinence in women with type 2 diabetes. J Urol 188(5):1816–1821PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Wang Z, Cheng Z, Cristofaro V, Li J, Xiao X, Gomez P, Ge R, Gong E, Strle K, Sullivan MP, Adam RM, White MF (2012) Olumi AF Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes. Diabetes 61(8):2134–2145PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Liu RT, Chung MS, Chuang YC, Lee JJ, Lee WC, Chang HW, Yang KD, Chancellor MB (2012) The presence of overactive bladder wet increased the risk and severity of erectile dysfunction in men with type 2 diabetes. J Sex Med 9(7):1913–1922PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Giovanni Palleschi
    • 1
    • 2
  • Antonio Luigi Pastore
    • 1
    • 2
  • Cristina Maggioni
    • 1
  • Andrea Fuschi
    • 1
  • Luca Pacini
    • 3
  • Vincenzo Petrozza
    • 3
  • Antonio Carbone
    • 1
    • 2
  1. 1.Unit of Urology ICOT, Department of Medical and Surgical Sciences and Biotechnologies, Faculty of Pharmacy and MedicineSapienza University of RomeLatinaItaly
  2. 2.Uroresearch® AssociationLatinaItaly
  3. 3.Department of Biotechnologies and Medico-Surgical SciencesSapienza University of RomeLatinaItaly

Personalised recommendations